Delphi advisor to Ardena in the acquisition of Syntagon Invest AB
Delphi has advised the Ardena group (Ardena) in the acquisition of Syntagon Invest AB and its subsidiaries Syntagon AB and Syntagon Baltic (jointly referred to as Syntagon).
Syntagon was established in 1999 and has sites in Sweden and Latvia with approximately 30 employees. Syntagon offers a comprehensive development package for Life Science ingredients and GMP manufacturing from early development to commercial manufacturing.
Ardena is a portfolio company of Mentha Capital and was formed in 2017, following the merging of three companies with complementary capabilities: Pharmavize in Belgium, Crystallics and Analytical Biochemical Laboratory (ABL) in the Netherlands. After the acquisitions of Syntagon and ChemConnection in 2018, Ardena now employs more than 225 scientists.
Delphi’s team mainly consisted of Fredrik Mörner (responsible partner) and Linn Strömberg.